Barely Significant
← all excerpts

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial.

Rheumatology (Oxford) · 2020 · PMC6909893 · PMID 31237947

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.